Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Turkey flag Turkey · Delayed Price · Currency is TRY
11.46
-0.43 (-3.62%)
At close: Dec 4, 2025
-14.22%
Market Cap 2.54B
Revenue (ttm) 532.64M
Net Income (ttm) -263.07M
Shares Out 220.00M
EPS (ttm) -1.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,891,795
Average Volume 4,595,199
Open 11.86
Previous Close 11.89
Day's Range 11.45 - 11.88
52-Week Range 9.60 - 16.45
Beta -0.19
RSI 48.24
Earnings Date Feb 27, 2026

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cyto... [Read more]

Industry Medical Devices
Sector Healthcare
Employees 223
Stock Exchange Istanbul Stock Exchange
Ticker Symbol ANGEN
Full Company Profile

Financial Performance

In 2024, IST:ANGEN's revenue was 529.83 million, an increase of 54.06% compared to the previous year's 343.92 million. Losses were -218.88 million, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.